-
In The News /Novartis CEO Vas Narasimhan discusses how to improve pandemic preparedness at the CNBC Evolve Global Summit.
-
Story /Bioengineers, immunologists and clinicians collaborate to explore a new approach to fighting cancer.
-
Story /The recently appointed leader of the Novartis’ digital research and development platform data42 is a strong believer that data and digital technologies will change the path of medical science.
-
Featured News /
Cell Therapies Pty Ltd has become the first approved CAR-T commercial manufacturing site in Australia, providing potentially faster access to CAR-T therapies to eligible patients in the region with life-threatening blood cancers.
Novartis global commercial CAR-T manufacturing footprint now spans four continents, bringing these transformative therapies closer to patients and healthcare professionals around the world. -
Story /Novartis researchers leverage in-house startup initiative to begin digital technology research collaboration.
-
Story /Our Global Head of Patient Affairs and Policy shares why it’s critical to engage patients throughout the drug development process.
-
Story /Meet our Vice President of Strategic Data and Digital at Novartis Oncology.
-
Story /New Global Head of Business Development and Licensing for research makes connections naturally, decisions scientifically.
Pagination
- ‹ Previous page
- 1
- …
- 104
- 105
- 106
- 107
- 108
- 109
- 110
- …
- 277
- › Next page